Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study

被引：0
|
作者：
Luigi Celio
Diego Cortinovis
Alessio Aligi Cogoni
Luigi Cavanna
Olga Martelli
Simona Carnio
Elena Collovà
Federica Bertolini
Fausto Petrelli
Alessandra Cassano
Rita Chiari
Francesca Zanelli
Salvatore Pisconti
Isabella Vittimberga
Antonietta Letizia
Andrea Misino
Angela Gernone
Erminio Bonizzoni
Sara Pilotto
Sabino De Placido
Emilio Bria
机构：
[1] Desenzano del Garda Hospital,Medical Oncology Unit, ASST del Garda
[2] ASST Monza San Gerardo Hospital,Medical Oncology Department
[3] Azienda Ospedaliero-Universitaria di Sassari,Medical Oncology Department
[4] Azienda Ospedaliera di Piacenza,Oncology Department
[5] ASL Frosinone,Medical Oncology
[6] San Luigi Gonzaga Hospital,Department of Oncology
[7] University of Turin,Cancer Centre Department – Oncology Unit
[8] ASST Ovest Milanese – Legnano Hospital,Department of Oncology and Hematology
[9] AOU Policlinico di Modena,Medical Oncology Unit
[10] ASST Bergamo Ovest,Comprehensive Cancer Center
[11] Fondazione Policlinico Universitario Agostino Gemelli,Medical Oncology
[12] IRCCS,Oncology Unit
[13] Università Cattolica del Sacro Cuore,Medical Oncology Unit
[14] AULSS6 Euganea,Medical Oncology Department
[15] IRCCS Santa Maria Nuova,Department of Oncology
[16] San Giuseppe Moscati Hospital,Department of Pneumology and Oncology
[17] ASST Lecco,Medical Oncology
[18] AORN dei Colli-Ospedale Monaldi,Medical Oncology Unit
[19] Clinical Cancer Center “Giovanni Paolo II” – IRCCS,Department of Clinical Science and Community, Section of Medical Statistics, Biometry and Epidemiology “G.A. Maccacaro”, Faculty of Medicine and Surgery
[20] University of Bari,Section of Oncology, Department of Medicine
[21] Policlinico di Bari,Clinical Medicine and Surgery Department
[22] University of Milan,undefined
[23] University and Hospital Trust of Verona,undefined
[24] University of Naples “Federico II”,undefined
来源：
BMC Cancer | / 22卷
关键词：
Cisplatin; Dexamethasone; NEPA; Quality of life; Functional living index-Emesis; Chemotherapy-induced nausea and vomiting (CINV);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study
    Celio, Luigi
    Cortinovis, Diego
    Cogoni, Alessio Aligi
    Cavanna, Luigi
    Martelli, Olga
    Carnio, Simona
    Collova, Elena
    Bertolini, Federica
    Petrelli, Fausto
    Cassano, Alessandra
    Chiari, Rita
    Zanelli, Francesca
    Pisconti, Salvatore
    Vittimberga, Isabella
    Letizia, Antonietta
    Misino, Andrea
    Gernone, Angela
    Bonizzoni, Erminio
    Pilotto, Sara
    De Placido, Sabino
    Bria, Emilio
    BMC CANCER, 2022, 22 (01)
  • [2] Dexamethasone-sparing regimens with NEPA (netupitant/palonosetron) for the prevention of chemotherapy-induced nausea and vomiting in older patients (>65 years) fit for cisplatin: A sub-analysis from a phase 3 study
    Celio, Luigi
    Bartsch, Rupert
    Aapro, Matti
    JOURNAL OF GERIATRIC ONCOLOGY, 2023, 14 (06)
  • [3] Retrospective Evaluation of a Dexamethasone Sparing Antiemetic Regimen: An Antiemetic Prophylaxis Study on NEPA (Netupitant Plus Palonosetron) for Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in Cancer Patients
    Agre, Suhas
    Agre, Madhura
    Pol, Pooja
    Tonse, Mubarakunnisa
    Mohanty, Mitasha
    Shaikh, Alfiya
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [4] Noninferiority study evaluating dexamethasone (DEX)-sparing regimens administered with NEPA, a fixed combination of netupitant and palonosetron, for the prevention of chemotherapy-induced nausea and vomiting (CINV) caused by high-dose cisplatin.
    Celio, Luigi
    Bonizzoni, Erminio
    Bria, Emilio
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Antiemetic Prophylaxis with NEPA (NETUPITANT/PALONOSETRON) and Dexamethasone to Prevent Chemotherapy-Induced Nausea and Vomiting (CINV) in Hodgkin'S Lymphoma Naive Patients Receiving ABVD Regimen: A Multicenter Phase Iia Study
    Nasso, Daniela
    Bolis, Silvia
    Abruzzese, Elisabetta
    Romano, Ilaria
    Patti, Caterina
    Di Renzo, Nicola
    Flenghi, Leonardo
    Stelitano, Caterina
    Mannina, Donato
    Sassone, Marianna
    De Stefano, Alberto
    Chiaramonte, Carlo
    Tesei, Cristiano
    Provenzano, Ida
    Cantonetti, Maria
    BLOOD, 2020, 136
  • [6] Netupitant-palonosetron (NEPA) for Preventing Chemotherapy-induced Nausea and Vomiting: From Clinical Trials to Daily Practice
    Aapro, Matti
    Jordan, Karin
    Scotte, Florian
    Celio, Luigi
    Karthaus, Meinolf
    Roeland, Eric
    CURRENT CANCER DRUG TARGETS, 2022, 22 (10) : 806 - 824
  • [7] Preventing chemotherapy-induced nausea and vomiting in patients with lung cancer: efficacy of NEPA (netupitant-palonosetron), the first combination antiemetic
    Hesketh, Paul J.
    Palmas, Marco
    Nicolas, Pierre
    SUPPORTIVE CARE IN CANCER, 2018, 26 (04) : 1151 - 1159
  • [8] Preventing chemotherapy-induced nausea and vomiting in patients with lung cancer: efficacy of NEPA (netupitant-palonosetron), the first combination antiemetic
    Paul J. Hesketh
    Marco Palmas
    Pierre Nicolas
    Supportive Care in Cancer, 2018, 26 : 1151 - 1159
  • [9] ONE DAY ANTIEMETIC PROPHYLAXIS WITH NEPA (NETUPITANT/PALONOSETRON) AND DEXAMETHASONE TO PREVENT CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IN HODGKIN'S LYMPHOMA NAIVE PATIENTS RECEIVING ABVD REGIMEN: A MULTICENTER PHASE IIA STUDY
    Cantonetti, M.
    Bolis, S. A. M.
    Abruzzese, E.
    Bosi, A.
    Patti, C.
    Di Renzo, N.
    Flenghi, L.
    Stelitano, C.
    Mannina, D.
    Sassone, M.
    De Stefano, A.
    Chiaramonte, C.
    Tesei, C.
    Provenzano, I.
    Nasso, D.
    HAEMATOLOGICA, 2020, 105 : S103 - S103
  • [10] A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)
    Zhang, L.
    Lu, S.
    Feng, J.
    Dechaphunkul, A.
    Chang, J.
    Wang, D.
    Chessari, S.
    Lanzarotti, C.
    Jordan, K.
    Aapro, M.
    ANNALS OF ONCOLOGY, 2018, 29 (02) : 452 - 458
12345